8-K - Vir Biotechnology, Inc. (0001706431) (Filer)
Published . Updated .
Key takeaways
- 8-K - Vir Biotechnology filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
- Exposed: VIR
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Vir Biotechnology filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
Directly affected
- VIR Vir Biotechnology+9.8% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Vir Biotechnology belongs to, so it often moves with news about it.
- AMGN Amgen+10.1% 30d
Amgen is a peer of Vir Biotechnology in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+15.7% 30d
Gilead Sciences is a peer of Vir Biotechnology in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+27.8% 30d
Moderna is a peer of Vir Biotechnology in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-17.1% 12d
argenx SE is a peer of Vir Biotechnology in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Vir Biotechnology in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VIR | -9.79% | -3.56% | base | after close | after close | after close | after close |
| XLV | -0.10% | +2.63% | base | after close | after close | after close | after close |
| AMGN | +1.13% | +3.87% | base | after close | after close | after close | after close |
| GILD | +2.11% | +4.54% | base | after close | after close | after close | after close |
| MRNA | -13.21% | +1.53% | base | after close | after close | after close | after close |
| ARGX | -5.82% | +0.29% | base | after close | after close | after close | after close |
| RVMD | -2.15% | +3.75% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-09 AccNo: 0001628280-26-071908 Size: 197 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Vir Biotechnology (VIR)
Vir Biotechnology (VIR) the next day, across 4 earlier stories: average +1.43%, largest gain +3.70%, largest drop -1.41%, from 4 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Vir Biotechnology (VIR) | the next day | +1.43% | +3.70% | -1.41% | 4 |
| Vir Biotechnology (VIR) | three days later | -5.39% | -3.77% | -7.57% | 3 |
Price since this story was published: Vir Biotechnology (VIR)
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | three days earlier | +3.87% | final price |
| AMGN | five days earlier | +1.13% | final price |
| ARGX | three days earlier | +0.29% | final price |
| ARGX | five days earlier | -5.82% | final price |
| GILD | three days earlier | +4.54% | final price |
| GILD | five days earlier | +2.11% | final price |
| MRNA | three days earlier | +1.53% | final price |
| MRNA | five days earlier | -13.21% | final price |
| RVMD | three days earlier | +3.75% | final price |
| RVMD | five days earlier | -2.15% | final price |
| Vir Biotechnology (VIR) | three days earlier | -3.56% | final price |
| Vir Biotechnology (VIR) | five days earlier | -9.79% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Trades by members of Congress and officials in the stocks in this story
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 25 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 48 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 75 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Vir Biotechnology, Inc. (0001706431) (Filer)”
Companies mentioned with this story
- VIR Vir Biotechnology
Vir Biotechnology (VIR) is linked, with no stored direction, high confidence in the 9 Nov 2026 story “8-K - Vir Biotechnology, Inc. (0001706431) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> VIR
How “8-K - Vir Biotechnology, Inc. (0001706431) (Filer)” reaches Vir Biotechnology (VIR)
On 9 Nov 2026, “8-K - Vir Biotechnology, Inc. (0001706431) (Filer)” is the story that connects Vir Biotechnology (VIR) to this story.
For Vir Biotechnology (VIR), the reason on file says SEC 8-K filing -> direct issuer disclosure -> VIR
Dates and price levels for Vir Biotechnology (VIR)
VIR traded between 9.91 and 12.44 across 20 sessions. The latest close on file is 12.21.
How strong the case is around Vir Biotechnology (VIR)
14 out of 100
“8-K - Vir Biotechnology, Inc. (0001706431) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.